Bixiye
QP 102-22 MHCP Pharmacy Benefit Exclusion for Imjudo® and Tecvayli™
Taariikhda uu dhaqangalayo Barnaamijka: Des 14, 2022
Natiijooyinka Raadinta
Soo bandhiga 1581 - 1590 ee natiijooyinka 3688
Bixiye
QP106-22 MHCP Pharmacy Benefit Exclusion Floxuridine
Taariikhda uu dhaqangalayo Barnaamijka: Des 14, 2022
Bixiye
QP109-22 New Provider Toolkit
Taariikhda uu dhaqangalayo Barnaamijka: Des 14, 2022
Bixiye
QP105-22 Provider Press Year-End 2022
Taariikhda uu dhaqangalayo Barnaamijka: Des 14, 2022
Bixiye
Vtama (tapinarof) - Commercial
Oggolaanshaha Hore
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Camzyos™ (mavacamten) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Vijoice (alpelisib) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Vijoice (alpelisib) - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP99-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 15, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022